Erythropoietin levels in children with obstructive sleep apnea

Nick D Kalogritsas1, Vasileios A Lachanas1, Panagiotis Liakos2

  • 1Department of Otorhinolaryngology, University Hospital of Larissa, Greece.

Insights

Serum erythropoietin (EPO) levels are elevated in children with obstructive sleep apnea (OSA). These findings suggest EPO may serve as a potential biomarker for diagnosing pediatric OSA.

Area of Science:

  • Pediatric Pulmonology
  • Sleep Medicine
  • Biomarker Discovery

Background:

  • High serum erythropoietin (EPO) levels are documented in adult obstructive sleep apnea (OSA).
  • Limited research exists on EPO levels in pediatric OSA.
  • Investigating EPO as a pediatric OSA biomarker is warranted.

Purpose of the Study:

  • To explore the relationship between serum EPO levels and pediatric OSA.
  • To assess the potential of EPO as a diagnostic biomarker in children with OSA.

Main Methods:

  • Prospective study involving children aged 4-12 years undergoing polysomnography (PSG).
  • Recruited 115 children: 86 with OSA (mild, moderate, severe) and 29 without OSA (AHI≤1).
  • Compared morning serum EPO levels between OSA and non-OSA groups.

Main Results:

  • Children with OSA exhibited significantly higher mean serum EPO levels (8.33 ± 4.10 mIU/ml) compared to the non-OSA group (5.46 ± 2.29 mIU/ml).
  • Serum EPO levels demonstrated a significant positive correlation with the apnea-hypopnea index (AHI) (p < 0.001).

Conclusions:

  • Serum EPO levels are significantly elevated in children with OSA compared to controls.
  • EPO shows promise as a potential biomarker for pediatric OSA.
  • Further research is recommended due to the novelty of this finding.
Abstract

Related Concept Videos

Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.9K
Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
241
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.1K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.9K
Factors Affecting Respiration01:24

Factors Affecting Respiration

Respiration is a crucial physiological function involving exchanging oxygen (O2) and carbon dioxide (CO2) between an organism and its environment. Various factors can impact this essential process:
7.9K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
56